From Name:
From Email:
To Name:
To Email:

Optional Message:


Stemedica posts Alzheimer's stem cell data

from Drug Discovery & Development

Stemedica International S.A., a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first results of an intravenous administration of allogeneic, human, ischemia-tolerant mesenchymal stem cells in a preclinical animal model of Alzheimer’s disease. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063